A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Bridgewater Associates, LP holds 70,462 shares of LNTH stock, worth $6.09 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
70,462
Previous 109,133 35.43%
Holding current value
$6.09 Million
Previous $8.76 Million 11.74%
% of portfolio
0.04%
Previous 0.05%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$77.7 - $123.62 $3 Million - $4.78 Million
-38,671 Reduced 35.43%
70,462 $7.73 Million
Q2 2024

Aug 14, 2024

BUY
$58.87 - $83.05 $1.93 Million - $2.72 Million
32,763 Added 42.9%
109,133 $8.76 Million
Q1 2024

May 14, 2024

BUY
$51.07 - $68.26 $239,977 - $320,753
4,699 Added 6.56%
76,370 $4.75 Million
Q4 2023

Feb 14, 2024

SELL
$55.6 - $77.89 $431,066 - $603,881
-7,753 Reduced 9.76%
71,671 $4.44 Million
Q3 2023

Nov 13, 2023

BUY
$60.27 - $90.75 $369,816 - $556,842
6,136 Added 8.37%
79,424 $5.52 Million
Q2 2023

Aug 11, 2023

SELL
$82.41 - $99.65 $680,129 - $822,411
-8,253 Reduced 10.12%
73,288 $6.15 Million
Q1 2023

May 12, 2023

BUY
$47.76 - $82.86 $90,744 - $157,434
1,900 Added 2.39%
81,541 $6.73 Million
Q4 2022

Feb 13, 2023

SELL
$48.76 - $77.67 $1.32 Million - $2.11 Million
-27,115 Reduced 25.4%
79,641 $4.06 Million
Q3 2022

Nov 10, 2022

BUY
$61.42 - $86.29 $4,422 - $6,212
72 Added 0.07%
106,756 $7.51 Million
Q2 2022

Aug 11, 2022

BUY
$55.54 - $72.65 $594,333 - $777,427
10,701 Added 11.15%
106,684 $7.04 Million
Q1 2022

May 13, 2022

BUY
$24.28 - $56.64 $552,418 - $1.29 Million
22,752 Added 31.07%
95,983 $5.31 Million
Q4 2021

Feb 14, 2022

BUY
$22.54 - $30.44 $170,965 - $230,887
7,585 Added 11.55%
73,231 $2.12 Million
Q3 2021

Nov 12, 2021

SELL
$24.23 - $28.59 $104,310 - $123,079
-4,305 Reduced 6.15%
65,646 $1.69 Million
Q2 2021

Aug 13, 2021

BUY
$19.51 - $27.64 $1.36 Million - $1.93 Million
69,951 New
69,951 $1.93 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $5.94B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track Ray Dalio's Portfolio

Track Ray Dalio Portfolio

Follow Ray Dalio (Bridgewater Associates, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.